Table 3.

Effects of Retinoic Acid Antagonists on CD437-Dependent Apoptosis and Caspase Activation

Treatment No. Viable Cells ×1,000 (% viability)Apoptotic Index (%) DEVD-amc Hydrolytic Activity (Fluorescence Arbitrary Units)
Control  518 ± 50 4.8 ± 2.0  8.5 ± 0.3  
 (76 ± 5)  
CD437 439 ± 24  52.4 ± 16.03-150 18.1 ± 0.83-150 
 (68 ± 1)  
CD3106  542 ± 43  3.8 ± 1.3 7.1 ± 0.2  
 (75 ± 5)  
CD2665  577 ± 55 4.0 ± 1.9  8.0 ± 1.7  
 (81 ± 5)  
CD3159 506 ± 53  11.9 ± 3.9  8.2 ± 1.3 
 (77 ± 6)  
CD437 + CD3106  448 ± 49 40.5 ± 13.33-150 17.7 ± 2.33-150 
 (75 ± 7) 
CD437 + CD2665  420 ± 20  44.8 ± 9.93-150 20.3 ± 1.33-150 
 (74 ± 2)  
CD437 + CD3159 440 ± 29  47.3 ± 3.33-150 22.2 ± 2.53-150 
 (67 ± 3) 
Treatment No. Viable Cells ×1,000 (% viability)Apoptotic Index (%) DEVD-amc Hydrolytic Activity (Fluorescence Arbitrary Units)
Control  518 ± 50 4.8 ± 2.0  8.5 ± 0.3  
 (76 ± 5)  
CD437 439 ± 24  52.4 ± 16.03-150 18.1 ± 0.83-150 
 (68 ± 1)  
CD3106  542 ± 43  3.8 ± 1.3 7.1 ± 0.2  
 (75 ± 5)  
CD2665  577 ± 55 4.0 ± 1.9  8.0 ± 1.7  
 (81 ± 5)  
CD3159 506 ± 53  11.9 ± 3.9  8.2 ± 1.3 
 (77 ± 6)  
CD437 + CD3106  448 ± 49 40.5 ± 13.33-150 17.7 ± 2.33-150 
 (75 ± 7) 
CD437 + CD2665  420 ± 20  44.8 ± 9.93-150 20.3 ± 1.33-150 
 (74 ± 2)  
CD437 + CD3159 440 ± 29  47.3 ± 3.33-150 22.2 ± 2.53-150 
 (67 ± 3) 

Cells (500,000/mL) were treated with CD437 (1 × 10−6 mol/L), CD3106 (1 × 10−5mol/L), CD2665 (1 × 10−5 mol/L), CD3159 (1 × 10−5 mol/L), or CD437 in combination with each of the other three compounds for 6 hours. At the end of treatment, aliquots of the cultures were stained with erythrosin for the determination of the number of cells and their viability, and with DAPI for the determination of the number of apoptotic cells. Remaining cells were obtained, homogenized, and the extract was assayed for DEVD-amc hydrolytic activity. Each value represents the mean ± SD of three replicate cultures.

F3-150

Statistically higher than control following the Student’st-test (P < .01).

or Create an Account

Close Modal
Close Modal